Column Capital Advisors, LLC Bei Gene, Ltd. Transaction History

Column Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$121.11 - $216.05 $363 - $648	-3 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$292.75 - $367.01 $585 - $734	-2 Reduced 40.0%	3 $1,000
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $3,405 - $5,155	-18 Reduced 78.26%	5 $1,000
Q2 2020 Aug 12, 2020	BUY	$123.9 - $195.41 $2,849 - $4,494	23 New	23 $4,000

212

45.1M

106K

93.1K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Column Capital Advisors, LLC with notifications on news.